| 前收市價 | 0.2000 |
| 開市 | 0.6000 |
| 買盤 | 0.0000 |
| 賣出價 | 0.3000 |
| 拍板 | 45.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.6000 - 0.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 80 |
Insider MonkeyHow Novo-Catalent Deal Affects Halozyme (HALO)?
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you […]
ZacksHalozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlace3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
If you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks can range from pre-revenue startups to global pharmaceutical giants. All it takes is one treatment to put the company on the map and provide outsized returns for its shareholders. Biotech is one of those growth sectors that have the potential to provide multibagger returns to your portfolio. Many fortunes have been made with a fortuitous investment in a Biotech stock at the right time. That time
